Poseida Therapeutics Raises $142 Million in Series C Financing
22 avr. 2019 07h00 HE
|
Poseida Therapeutics, Inc.
SAN DIEGO, April 22, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create...